Methods: An electronic survey was distributed to medical residents in April 2015. The survey obtained respondent demographics and perspective on the effectiveness and structure of ABR. Responses consist of a 5-point Likert scale from “strongly agree” to “strongly disagree”.
Results: A total of 64 medical residents who have attended at least 1 ABR participated in the survey: 31.3% (20/64) PGY-1, 34.4% (22/64) PGY-2, and 34.4% (22/64) PGY-3. Three areas ranked with the most strongly agreed was the participation of an ID PharmD as beneficial (54.7%; 35/64), followed by improvement in understanding the use of the antibiogram (32.8%; 21/64) and raising awareness in antimicrobial stewardship (29.7%; 19/64).
Majority of respondents strongly agreed or agreed that ABR increased their confidence, knowledge, and understanding in the following: prescribing abx therapy (87.5%; 56/64), appropriate duration of abx therapy (89.1%; 57/64), abx dosing and drug monitoring (84.4%; 54/64), value of obtaining pre-abx cultures (82.8%; 53/64), and using the institution’s antibiogram (89.1%; 57/64). Majority of respondents also strongly agreed or agreed that ABR raised their awareness in antimicrobial stewardship (92.2%; 59/64) and encouraged them to be actively involved in antimicrobial stewardship (87.5%; 56/64). Respondents also strongly agreed or agreed that once weekly rounds is sufficient and participation of an ID PharmD as beneficial (81.3%; 52/55 and 85.9%; 55/64, respectively).
Conclusion: Medical residents’ perspective on ABR was overwhelmingly positive. Once weekly ABR with participation of an ID PharmD demonstrated to be an effective education tool to increase knowledge in appropriate abx use and promote antimicrobial stewardship.
Y. Lee, None